|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: VERMONT PURE HOLDINGS LTD, 10-Q, 2000-06-16 |
Next: TRANSKARYOTIC THERAPIES INC, SC 13D, 2000-06-16 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
</LEGEND>
<CIK> 0000885040
<NAME> Vermont Pure Holdings, LTD and Subsidiary
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> OCT-31-2000
<PERIOD-START> NOV-30-1999
<PERIOD-END> APR-30-2000
<EXCHANGE-RATE> 1
<CASH> 1,562,762
<SECURITIES> 2,941,397
<RECEIVABLES> 4,516,309
<ALLOWANCES> 441,786
<INVENTORY> 2,802,611
<CURRENT-ASSETS> 12,850,163
<PP&E> 19,746,046
<DEPRECIATION> 5,765,969
<TOTAL-ASSETS> 41,109,031
<CURRENT-LIABILITIES> 6,550,152
<BONDS> 0
0
0
<COMMON> 10,340
<OTHER-SE> 13,291,423
<TOTAL-LIABILITY-AND-EQUITY> 13,301,763
<SALES> 14,648,434
<TOTAL-REVENUES> 14,648,434
<CGS> 5,544,124
<TOTAL-COSTS> 5,544,124
<OTHER-EXPENSES> 8,822,657
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 734,274
<INCOME-PRETAX> 0
<INCOME-TAX> 0
<INCOME-CONTINUING> (179,734)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (179,734)
<EPS-BASIC> (0.02)
<EPS-DILUTED> (0.02)
</TABLE>
|
|